Event: BioNetwork Asia 2011
Dates: August 24 - 25, 2011
Venue: Grand Hyatt, Singapore
With the tightening of regulatory pressures resulting in few FDA approvals, blockbuster drugs worth more than $100 billion are set to expire by 2014 and the drying pipelines of pharmaceutical industry, cost cutting pressures are mounting on pharmaceutical companies, especially the big ones.
These pressures are expected to drive these companies towards Asia to search for partnerships, perform their R&D activities and lowering cost in the hope of driving further and greater innovation.
The BioNetwork Asia will help you position yourself at the front of the pipeline race, meet the right partners and leave with a complete understanding on the most important issues and solutions, including:
- Asian pharma industry trends and growth potential in the next 5 years;
- Tapping on the potential of Public Private Partnerships (PPP) in Asia;
- Achieving effective deal making strategies between East and West;
- Debate on government funded projects – blessing or a curse;
- Tackling pricing and reimbursement issues in China;
- Assessing the growth potential in India - the drivers of strategy, growth and innovation enabling
business development;
- Case study: Identifying the market access strategies in Asia - diversity & challenge;
- New model for sharing risks and reaping rewards;
- Evaluating new projects and innovations from the perspective of a biotech;
- Opportunities for pharmaceutical R&D innovation and partnership in Asia; and
- Harnessing academia-industry partnerships to drive drug discovery.